Anti-chrondrosarcoma compounds
US7795225B2 · kind B2 · utility
0Cited by
28References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2006 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Oct 31, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents. The inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases. The peptide inhibitors of the invention can be formulated into therapeutic compositions, lotions, creams and wound dressings.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.